Oprah Winfrey at Paris Fashion Week
On March 5, 2026, Oprah Winfrey and her longtime friend Gayle King attended the Chloé show during Paris Fashion Week in Paris, France. The duo made a stylish appearance, with Oprah wearing dark blue jeans and a cropped tan suede jacket, while both donned snake-effect Chloé Cleia pumps. Oprah opted for a darker beige version of the pumps, while Gayle chose a lighter off-white pair. The Cleia pumps feature a T-bar construction and a 70 mm curved stiletto heel, showcasing the latest in fashion trends.
Weight Loss Medication Discussion
Oprah has been open about her journey with weight management, confirming that she has been taking weight loss medication since 2023. In a January 2025 podcast, she mentioned using a GLP-1 agonist to assist with her weight management efforts. While she did not specify if the medication is Ozempic, she stated, “I now use it as I feel I need it, as a tool to manage not yo-yoing. It quiets the food noise.” This statement has sparked public interest and concern regarding her health.
Following her recent appearance, social media reactions have varied. One anonymous user questioned, “What in the Ozempic Oprah is going on here?” while another expressed concern, stating, “I’m afraid Oprah may OD on Ozempic. Welfare check, please!” These comments reflect a mix of curiosity and worry among fans regarding her health choices.
Future Implications
Observers note that Oprah’s candidness about her weight loss journey and medication use may influence public perceptions of weight management and health. As she continues to navigate her personal health choices, it remains to be seen how this will impact her public image and the discussions surrounding weight loss medications.
Details remain unconfirmed regarding the specific medication she is using, but Oprah’s approach to managing her weight has opened up conversations about the broader implications of such treatments in society. As she continues to share her experiences, it is likely that both her supporters and critics will remain engaged in the dialogue surrounding her health and lifestyle choices.